Teriflunomide in relapsing multiple sclerosis: therapeutic utility

por Freedman, Mark S.
Publicado 2013

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

por Freedman, Mark S
Publicado 2014

Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome

por Freedman, Mark S.
Publicado en Ther Adv Neurol Disord (2014)

Multiple sclerosis therapeutic strategies: Use second-line agents as first-line agents when time is of the essence

por Freedman, Mark S.
Publicado en Neurol Clin Pract (2011)

Letter to the Editor: Consensus Statement on Neurofilament Proteins in Multiple Sclerosis Under Development by Consortium of Multiple Sclerosis Centers (CMSC) Expert Panel

por Freedman, Mark, Gnanapavan, Sharmilee
Publicado en Int J MS Care (2020)

Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned

por Atkins, Harold L., Freedman, Mark S.
Publicado 2012

Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

por Atkins, Harold L., Freedman, Mark S.
Publicado en Neurotherapeutics (2017)

Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER study

por Freedman, Mark S, Morawski, Julia, Thangavelu, Karthinathan
Publicado en Mult Scler J Exp Transl Clin (2018)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021

por Freedman, Mark S., Ault, Kevin, Bernstein, Henry
Publicado en MMWR Morb Mortal Wkly Rep (2021)

Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases

por D’Ambrosio, Daniele, Freedman, Mark S., Prinz, Joerg
Publicado en Ther Adv Chronic Dis (2016)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?

por Thebault, Simon, Booth, Ronald A., Freedman, Mark S.
Publicado en Biomedicines (2020)

HIV risks and testing behavior among Asians and Pacific Islanders: results of the HIV Testing Survey, 2002-2003.

por Kahle, Erin M., Freedman, Mark S., Buskin, Susan E.
Publicado 2005

Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis

por Freedman, Mark S, Kaplan, Johanne M, Markovic-Plese, Silva
Publicado 2013

Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis

por Rush, Carolina A., Atkins, Harold L., Freedman, Mark S.
Publicado en Cold Spring Harb Perspect Med (2019)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020

por Freedman, Mark S., Hunter, Paul, Ault, Kevin, Kroger, Andrew
Publicado en MMWR Morb Mortal Wkly Rep (2020)

Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience

por Alnajashi, Hind A., Alshamrani, Foziah J., Freedman, Mark S.
Publicado en Neurosciences (Riyadh) (2018)

Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-infected Men Who have Sex with Men in the United States

por Lin, Xia, Mattson, Christine L., Freedman, Mark, Skarbinski, Jacek
Publicado en AIDS Behav (2017)

A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo

por Vermersch, Patrick, Radue, Ernst-Wilhelm, Putzki, Norman, Ritter, Shannon, Merschhemke, Martin, Freedman, Mark S
Publicado en Mult Scler J Exp Transl Clin (2017)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation

por Thebault, Simon, Booth, Ronald A., Rush, Carolina A., MacLean, Heather, Freedman, Mark S.
Publicado en Front Neurosci (2021)

Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center

por Walker, Lisa A.S., Gardner, Courtney, Freedman, Mark S., MacLean, Heather, Rush, Carolina, Bowman, Marjorie
Publicado en Int J MS Care (2019)